Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by jackthebear1on Nov 30, 2021 8:15am

133 Views

Post# 34179112

Just a thought

I think it possible that due to our current shareprice there are funds that can:t buy yet and I also think that the milestones achieved have fallen on deaf ears because the gravity of what has been achieved is not easily understood by the average investor.
That will change and when it does there will be a feeding frenzy on the stock.
I also believe big pharma will start to look at lot closer at Tetra very soon and a massive buyout offer could be in the cards.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec